Cutler Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $15K | Sell |
200
-400
| -67% | -$30K | ﹤0.01% | 561 |
|
|
2023
Q4 | $47K | Sell |
600
-200
| -25% | -$15.7K | ﹤0.01% | 674 |
|
|
2023
Q3 | $55K | Buy |
+800
| New | +$55K | 0.01% | 683 |
|
|
2023
Q2 | – | Sell |
-2,156
| Closed | -$132K | – | 1391 |
|
|
2023
Q1 | $132K | Sell |
2,156
-3,170
| -60% | -$194K | 0.01% | 437 |
|
|
2022
Q4 | $410K | Sell |
5,326
-7,039
| -57% | -$542K | 0.03% | 307 |
|
|
2022
Q3 | $551K | Buy |
12,365
+8,995
| +267% | +$401K | 0.04% | 245 |
|
|
2022
Q2 | $129K | Sell |
3,370
-4,450
| -57% | -$170K | 0.01% | 602 |
|
|
2022
Q1 | $323K | Sell |
7,820
-12,610
| -62% | -$521K | 0.02% | 455 |
|
|
2021
Q4 | $771K | Buy |
20,430
+3,076
| +18% | +$116K | 0.03% | 319 |
|
|
2021
Q3 | $571K | Buy |
17,354
+12,804
| +281% | +$421K | 0.03% | 385 |
|
|
2021
Q2 | $306K | Buy |
4,550
+775
| +21% | +$52.1K | 0.01% | 575 |
|
|
2021
Q1 | $213K | Sell |
3,775
-2,912
| -44% | -$164K | 0.01% | 649 |
|
|
2020
Q4 | $544K | Buy |
6,687
+5,187
| +346% | +$422K | 0.03% | 327 |
|
|
2020
Q3 | $106K | Sell |
1,500
-2,170
| -59% | -$153K | 0.01% | 656 |
|
|
2020
Q2 | $301K | Buy |
3,670
+1,270
| +53% | +$104K | 0.02% | 340 |
|
|
2020
Q1 | $141K | Sell |
2,400
-1,050
| -30% | -$61.7K | 0.01% | 518 |
|
|
2019
Q4 | $356K | Sell |
3,450
-7,120
| -67% | -$735K | 0.02% | 380 |
|
|
2019
Q3 | $213K | Buy |
10,570
+2,520
| +31% | +$50.8K | 0.02% | 418 |
|
|
2019
Q2 | $207K | Sell |
8,050
-5,250
| -39% | -$135K | 0.02% | 454 |
|
|
2019
Q1 | $189K | Buy |
+13,300
| New | +$189K | 0.02% | 460 |
|